冠心病行经皮冠状动脉介入治疗术后支架内再狭窄发生的相关危险因素  

Risk Factors Associated with In -stent Restenosis after Percutaneous Coronary Intervention for Coronary Heart Disease

作　　者：金鹏[1] Jin Peng(Department of Cardiology, Luohe Central Hospital, Luohe 462000, Chin)

机构地区：[1]漯河市中心医院心内科,河南漯河462000

出　　处：《医学新知》2017年第3期241-242,247,共3页New Medicine

摘　　要：目的分析冠心病行经皮冠状动脉介入治疗术（PCI）后支架内再狭窄（ISR）发生的相关危险因素。方法选取2014年2月～2015年5月于我院行PCI手术的冠心病患者140例，其中术后发生ISR55例，未发生ISR85例。回顾性分析两组患者的性别、年龄、合并症、生化指标、支管直径及长度等资料，探讨ISR的危险因素。结果吸烟、糖尿病、支架直径、脂蛋白[Lp（a）]、纤维蛋白原（FIB）、尿酸（UA）是ISR的独立危险因素（P〈0．05）。结论冠心病行PCI治疗应尽量选用大直径支架，术后戒烟，并采取相应措施降低血糖，控制Lp（a）、FIB、UA，尽可能避免术后ISR的发生。Objective To analyze related risk factors associated with in -stent restenosis （ISR）after percutaneous coronary intervention（PCI）for coronary heart disease. Methods A total of Id0 patients undergoing PCI were selected from Feb. 2014 to May. 2015, in which 55 patients with ISR and 85 patients without ISR. Gender, age, complications, biochemical indexes, diameter and length of branch tube were analyzed retrospectively to explore risk factors of ISR. Results Smoking,diabetes,stent diameter,lipoprotein[Lp（a） ] ,fibrinogen（FIB）and uric acid（UA）were inde- pendent risk factors of ISR （ P 〈 0.05 ）. Conclusion PCI therapy for coronary heart disease should choose big diame- ter stents, quit smoking after operation, and adopt corresponding measures to control blood glucose, Lp （a） , FIB and UA in order to avoid the occurrence of postoperative ISR.

关 键 词：冠心病 支架内再狭窄 危险因素 经皮冠状动脉介入治疗术 

分 类 号：R541.4[医药卫生—心血管疾病]